Notícias

Voltar

Academic development of medicines in Europe (Associação das Ligas Europeias Contra o Cancro)

Academic development of medicines in Europe (Associação das Ligas Europeias Contra o Cancro)
The Association of European Cancer Leagues (ECL) and the MEPs Against Cancer (MAC) Interest Group are organising an online event on the academic development of medicines in Europe hosted by MEP Véronique Trillet-Lenoir, Co-Chair of MAC Interest Group.
 
Webinar: The potential for academic development of medicines in Europe
29 March 2023, 15:00-16:30 CET, Online
Registration open: 13 March 2023
 
Both medical and technological developments have led to the increased provision of cancer medicines on the market, making it possible for cancer patients to live longer with a better quality of life. However, currently, the only way to bring innovative therapies to patients is via a commercial route, with extremely high prices.
 
With this event, ECL wants to shine a light on the role that academia can play in the development and availability of innovative cell and gene therapies. ECL will also engage panellists representing EU institutions, the European Medicines Agency, health technology assessment bodies, patient representatives, and researchers in a discussion on the main bottlenecks that hinder such pathway of medicines development and how to overcome them.
 
08 de Março 2023

Voltar

Sugestões

Apoios & Parcerias